COVID testing company invests £ 2million in second Mersey site
In February, BioGrad Diagnostics announced it would create 120 new jobs in the Liverpool city area and is now investing £ 2million in a second site thanks to increased demand for COVID testing. Tony McDonough Reports
Liverpool lab company BioGrad Diagnostics is investing more than £ 2million in a new site in the city of Liverpool area due to demand for COVID-19 test rockets.
Based at Liverpool Science Park, BioGrad will be opening a new base at St Hugh’s House on Stanley Road in Bootle. Open on June 20, it will include a clinic, a call center for customer service, marketing and HR services over 7,500 square feet on two floors.
BioGrad previously announced an expansion in the city area, creating 120 new jobs. This follows the launch of five more clinics since December 2020, including sites in Manchester and three sites in London.
And, in response to the easing of restrictions on international travel, BioGrad has made its testing services more accessible by almost halving the price of essential tests needed by the public to travel abroad to £ 60. He provides results within 24 hours of arrival at his labs.
Dr Natalie Kenny, CEO of BioGrad Diagnostics, said: “Over the past 14 months, we have helped move the country forward by providing rapid and accurate testing, while trying to remain affordable to meet increased needs. the public and ensure the safety of people in the fight against COVID-19.
“We process tens of thousands of tests per week. Opening up to Bootle is further proof of our growing success. We are already looking for other locals in the city area.